Azithromycin in the treatment of Legionella pneumonia requiring hospitalization
- PMID: 14614670
- DOI: 10.1086/379329
Azithromycin in the treatment of Legionella pneumonia requiring hospitalization
Abstract
Azithromycin is highly active against Legionella pneumophila and has been shown to be efficacious in animal models and in clinical studies of patients with legionnaires disease. This open, prospective, multicenter trial evaluated azithromycin for the treatment of legionnaires disease. Twenty-five hospitalized patients with community-acquired pneumonia and a positive result of a L. pneumophila serogroup 1 urinary antigen assay received monotherapy with intravenous azithromycin (500 mg/day) for 2-7 days, followed by oral azithromycin (1500 mg administered over the course of 3 or 5 days). The mean total duration of intravenous plus oral therapy was 7.92 days. The overall cure rate among clinically evaluable patients was 95% (20 of 21 patients) at 10-14 days after therapy and 96% (22 of 23 patients) at 4-6 weeks after therapy. The results of this study support previously reported data demonstrating that azithromycin is both safe and efficacious for the treatment of hospitalized patients with legionnaires disease.
Similar articles
-
Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.Int J Tuberc Lung Dis. 2010 Apr;14(4):495-9. Int J Tuberc Lung Dis. 2010. PMID: 20202309
-
Legionellosis.Semin Respir Crit Care Med. 2005 Dec;26(6):625-34. doi: 10.1055/s-2005-925526. Semin Respir Crit Care Med. 2005. PMID: 16388431 Review.
-
[Community-acquired pneumonia due to Legionella pneumophila serogroup 1. Study of 97 cases].Enferm Infecc Microbiol Clin. 2003 Oct;21(8):394-400. Enferm Infecc Microbiol Clin. 2003. PMID: 14525703 Review. Spanish.
-
[Treatment of pneumonia caused by Legionella with azithromycin].Rev Esp Quimioter. 1998 Jun;11(2):147-51. Rev Esp Quimioter. 1998. PMID: 9795300 Clinical Trial. Spanish.
-
Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study.Scand J Infect Dis. 1995;27(5):503-5. doi: 10.3109/00365549509047054. Scand J Infect Dis. 1995. PMID: 8588143 Clinical Trial.
Cited by
-
Severe ARDS Secondary to Legionella Pneumonia Requiring VV ECMO in the Setting of Newly Diagnosed Hairy Cell Leukemia.J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096211065618. doi: 10.1177/23247096211065618. J Investig Med High Impact Case Rep. 2022. PMID: 35038889 Free PMC article.
-
Atypical bacterial pneumonia in the HIV-infected population.Pneumonia (Nathan). 2017 Aug 25;9:12. doi: 10.1186/s41479-017-0036-z. eCollection 2017. Pneumonia (Nathan). 2017. PMID: 28856082 Free PMC article. Review.
-
Atypical Pneumonia: Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia.Clin Chest Med. 2017 Mar;38(1):45-58. doi: 10.1016/j.ccm.2016.11.011. Epub 2016 Dec 24. Clin Chest Med. 2017. PMID: 28159161 Free PMC article. Review.
-
Comparison of sputum microbiome of legionellosis-associated patients and other pneumonia patients: indications for polybacterial infections.Sci Rep. 2017 Jan 6;7:40114. doi: 10.1038/srep40114. Sci Rep. 2017. PMID: 28059171 Free PMC article.
-
Retrospective analysis of azithromycin versus fluoroquinolones for the treatment of legionella pneumonia.P T. 2014 Mar;39(3):203-5. P T. 2014. PMID: 24790398 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical